Fractyl Health, Inc. Common Stock (GUTS)
USD 1.1
(-3.51%)
USD 1.1
(-3.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 340.19 Million USD | 32.1% |
| 2022 | 257.53 Million USD | 23.3% |
| 2021 | 208.86 Million USD | 20.27% |
| 2020 | 173.67 Million USD | 22.11% |
| 2019 | 142.22 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -61.22 Million USD | -118.0% |
| 2024 Q2 | -41.53 Million USD | 32.17% |
| 2023 FY | 340.19 Million USD | 32.1% |
| 2023 Q1 | 49.26 Million USD | -80.87% |
| 2023 Q4 | 340.19 Million USD | 14.15% |
| 2023 Q2 | 9.8 Million USD | -80.09% |
| 2023 Q3 | 298.02 Million USD | 2938.6% |
| 2022 Q4 | 257.53 Million USD | 0.0% |
| 2022 FY | 257.53 Million USD | 23.3% |
| 2021 Q3 | 199.2 Million USD | 0.0% |
| 2021 FY | 208.86 Million USD | 20.27% |
| 2021 Q4 | 208.86 Million USD | 4.85% |
| 2020 Q4 | 173.67 Million USD | 0.0% |
| 2020 FY | 173.67 Million USD | 22.11% |
| 2019 FY | 142.22 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 708.146% |
| Alkermes plc | -166.73 Million USD | 304.03% |
| Agenus Inc. | 274.13 Million USD | -24.098% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 81.807% |
| Aptorum Group Limited | 1.35 Million USD | -24968.936% |
| Ardelyx, Inc. | 34.51 Million USD | -885.735% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -7848.528% |
| Bicycle Therapeutics plc | -481.46 Million USD | 170.658% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -840.732% |
| ChromaDex Corporation | -24.04 Million USD | 1514.658% |
| Chimerix, Inc. | -25.51 Million USD | 1433.217% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -4782.223% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 1536.825% |
| CRISPR Therapeutics AG | -150.84 Million USD | 325.528% |
| Precision BioSciences, Inc. | -85.41 Million USD | 498.311% |
| Dyadic International, Inc. | -6.37 Million USD | 5433.831% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 2235.172% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4338.317% |
| Lantern Pharma Inc. | -21.7 Million USD | 1667.491% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 407.768% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 4082.091% |
| Incyte Corporation | -3.17 Billion USD | 110.715% |
| IO Biotech, Inc. | -140.69 Million USD | 341.791% |
| Jaguar Health, Inc. | 29.39 Million USD | -1057.487% |
| Novavax, Inc. | -298.29 Million USD | 214.048% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -6274.311% |
| Opthea Limited | 28.15 Million USD | -1108.196% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 2126.309% |
| ContextLogic Inc. | -232 Million USD | 246.637% |
| MiMedx Group, Inc. | -33.9 Million USD | 1103.501% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -3236.9% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 14782.479% |
| NextCure, Inc. | -6.47 Million USD | 5352.385% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 773.644% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 5433.077% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -2696.921% |
| Vaxcyte, Inc. | -368.22 Million USD | 192.388% |
| PDS Biotechnology Corporation | -32.7 Million USD | 1140.075% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -1868.961% |
| Pharming Group N.V. | 109.8 Million USD | -209.822% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 2055.605% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 294.143% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1936.931% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1936.931% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 4891.507% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 5905.41% |
| Acelyrin, Inc. | -216.9 Million USD | 256.843% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 6163.829% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 19833.005% |
| Summit Therapeutics Inc. | 34.67 Million USD | -881.13% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 5100.691% |
| Senti Biosciences, Inc. | 1.74 Million USD | -19451.552% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 284.282% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 539.242% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 5711.96% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -340884.675% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -54071.497% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 390.652% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 302.218% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -206.843% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 4578.633% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 363.486% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -4834.254% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 240.367% |
| Immix Biopharma, Inc. | -17.5 Million USD | 2042.896% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 207.418% |
| MEI Pharma, Inc. | -3.7 Million USD | 9282.105% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -2619.183% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -110.333% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -1124.038% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4338.317% |
| Precigen, Inc. | -481 Thousand USD | 70827.027% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -2316.0% |
| AlloVir, Inc. | -62.69 Million USD | 642.648% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 711.711% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -451.677% |
| ImmuCell Corporation | 10.99 Million USD | -2995.356% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 320.698% |
| Onconetix, Inc. | 5.33 Million USD | -6280.963% |
| PureTech Health plc | -167.19 Million USD | 303.471% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 1216.865% |
| Elevation Oncology, Inc. | -19.11 Million USD | 1879.459% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 7030.067% |
| Seer, Inc. | -4.24 Million USD | 8123.514% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 1515.306% |
| Innoviva, Inc. | 255.56 Million USD | -33.117% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 708.974% |
| ESSA Pharma Inc. | -33.62 Million USD | 1111.841% |
| GlycoMimetics, Inc. | -40.98 Million USD | 930.064% |
| GT Biopharma, Inc. | -1.02 Million USD | 33419.98% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 601.891% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -455.36% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 353.729% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 2555.232% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 1278.294% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 451684.942% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 1202.317% |
| Aptose Biosciences Inc. | -8.19 Million USD | 4251.348% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 10972.325% |
| Soligenix, Inc. | -4.95 Million USD | 6970.45% |
| Century Therapeutics, Inc. | 847 Thousand USD | -40064.935% |
| Kura Oncology, Inc. | -20.11 Million USD | 1791.008% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 931.249% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 4150.929% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -18574.751% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 10741.132% |
| Autolus Therapeutics plc | -186.59 Million USD | 282.314% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 789.999% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 223.352% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -892.754% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -106.973% |
| GRI Bio, Inc. | -1.79 Million USD | 19063.043% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 3887.101% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 1122.934% |
| IGM Biosciences, Inc. | -72.6 Million USD | 568.552% |
| INmune Bio, Inc. | -25.41 Million USD | 1438.778% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -125.369% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 771.543% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2193.601% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 11892.226% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -794.902% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 926.022% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -966.95% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 9.989% |
| Verastem, Inc. | -37.27 Million USD | 1012.595% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 3849.554% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 755.966% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 2347.75% |
| Histogen Inc. | -7.48 Million USD | 4643.836% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 1674.489% |
| Surrozen, Inc. | -32.66 Million USD | 1141.504% |
| Organovo Holdings, Inc. | -1.5 Million USD | 22674.453% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 8193.207% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -1694.268% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -12904.472% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -8085.683% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 4159.073% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 883.106% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 2433.815% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 207.389% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 47214.783% |
| Apollomics, Inc. | -27.39 Million USD | 1341.822% |
| Amarin Corporation plc | -191.04 Million USD | 278.076% |
| Mesoblast Limited | 55.96 Million USD | -507.896% |
| Turnstone Biologics Corp. | -14.58 Million USD | 2432.673% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 1445.077% |
| Synaptogenix, Inc. | -28.66 Million USD | 1286.948% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 36445.833% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -598.098% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 39561.935% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 4781.988% |
| Exelixis, Inc. | -73.05 Million USD | 565.704% |
| Better Therapeutics, Inc. | -860 Thousand USD | 39657.791% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 1516.72% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 240.944% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -46118.274% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 4673.687% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -27028.947% |
| Gritstone bio, Inc. | 39.49 Million USD | -761.476% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 504.51% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 13024.73% |
| Avid Bioservices, Inc. | 169.72 Million USD | -100.437% |
| Insmed Incorporated | 721.62 Million USD | 52.856% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 3821.452% |
| MediWound Ltd. | -5.32 Million USD | 6492.277% |
| OmniAb, Inc. | 9.2 Million USD | -3596.588% |
| Alector, Inc. | -35.63 Million USD | 1054.617% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -295.711% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 7003.348% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -2469.658% |
| Zai Lab Limited | -775 Million USD | 143.896% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 0.105% |
| Aura Biosciences, Inc. | -21.52 Million USD | 1680.474% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 512.46% |
| Immunic, Inc. | -45.34 Million USD | 850.324% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 276.072% |
| Veracyte, Inc. | -203.82 Million USD | 266.907% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 46.702% |
| FibroGen, Inc. | 56.76 Million USD | -499.287% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -3720.292% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 12133.503% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 16531.875% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 92.589% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 10282.49% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 304.982% |
| TG Therapeutics, Inc. | 17.86 Million USD | -1804.585% |
| Galecto, Inc. | -21.21 Million USD | 1703.493% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 1530.301% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 78.323% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 1490.148% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 3056.435% |
| XBiotech Inc. | -200.02 Million USD | 270.079% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 504.51% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -7413.185% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 1064.742% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 540.567% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -5877.807% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 299.629% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 468.282% |
| Vaxxinity, Inc. | 10.13 Million USD | -3257.649% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 53.794% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 3259.465% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 615.794% |
| NexImmune, Inc. | -3.13 Million USD | 10956.278% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 9953.149% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 2351.253% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 1355.339% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 3890.051% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 273186.093% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 938.502% |
| Ainos, Inc. | 4.07 Million USD | -8242.398% |
| Pluri Inc. | 22.82 Million USD | -1390.197% |
| Prothena Corporation plc | -608.34 Million USD | 155.922% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 386.467% |
| Celularity Inc. | 65.19 Million USD | -421.855% |
| Rallybio Corporation | -24.1 Million USD | 1511.489% |
| Cue Biopharma, Inc. | -33.81 Million USD | 1105.935% |
| MeiraGTx Holdings plc | -40.3 Million USD | 944.119% |
| Omeros Corporation | 331.17 Million USD | -2.724% |
| Humacyte, Inc. | -22.48 Million USD | 1612.928% |
| Immunocore Holdings plc | -358.59 Million USD | 194.87% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 1484.321% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 1200.926% |
| Blueprint Medicines Corporation | 702.83 Million USD | 51.597% |
| CalciMedica, Inc. | -5.53 Million USD | 6251.844% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 280.744% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 3430.693% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 949.707% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 1123.057% |
| Pulmatrix, Inc. | -10.41 Million USD | 3365.787% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 5791.768% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 991.922% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 405.378% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 667.525% |
| Cytokinetics, Incorporated | 642.37 Million USD | 47.04% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 5942.298% |
| Nutriband Inc. | -251.65 Thousand USD | 135282.808% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 1097.09% |
| Vor Biopharma Inc. | 4.3 Million USD | -7811.558% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 105.636% |
| Evogene Ltd. | -19.63 Million USD | 1832.693% |
| ProKidney Corp. | -56.23 Million USD | 704.945% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 798.958% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 3782.907% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 75.057% |
| CorMedix Inc. | -43.05 Million USD | 890.191% |
| BioLineRx Ltd. | 7.33 Million USD | -4537.364% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 1338.656% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -637.203% |
| Atai Life Sciences N.V. | -28.55 Million USD | 1291.249% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -15151.853% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 1591.046% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -1818.224% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 553.149% |
| MediciNova, Inc. | -50.78 Million USD | 769.897% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 531.695% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1512422.738% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5372.256% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 270.251% |
| Biomea Fusion, Inc. | -166.57 Million USD | 304.237% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 290.081% |
| Mereo BioPharma Group plc | -51.46 Million USD | 760.975% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 458.691% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 215.808% |
| Absci Corporation | -72.59 Million USD | 568.604% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -7350.657% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 245.112% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 461.101% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 455.498% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 970.67% |
| Allakos Inc. | -24.97 Million USD | 1462.15% |
| Imunon, Inc. | -4.21 Million USD | 8173.302% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 2407.672% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 351.253% |
| BioAtla, Inc. | -109.01 Million USD | 412.076% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -46118.274% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 36329.712% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -2743.03% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 1704.476% |
| XOMA Corporation | -29 Million USD | 1273.093% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 2154.33% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 3873.259% |
| aTyr Pharma, Inc. | -7.44 Million USD | 4667.016% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 372.952% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 263.427% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 515.996% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 466.738% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 39695.36% |
| Akari Therapeutics, Plc | -3.84 Million USD | 8947.776% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -20862.419% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 75.364% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 28732.857% |
| UroGen Pharma Ltd. | 4.39 Million USD | -7647.597% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -199.783% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -472645.338% |
| Orgenesis Inc. | 21.78 Million USD | -1461.683% |
| Entera Bio Ltd. | -10.62 Million USD | 3300.649% |
| GH Research PLC | -78.07 Million USD | 535.72% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 1626.368% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 1376.106% |
| Xencor, Inc. | 29.64 Million USD | -1047.608% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 17370.531% |
| Replimune Group, Inc. | 1.41 Million USD | -23993.272% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 139008.08% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 369.107% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 28732.857% |
| Portage Biotech Inc. | -4.98 Million USD | 6929.894% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1512422.738% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 614.499% |
| OncoCyte Corporation | -6.56 Million USD | 5283.559% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -37808.633% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 7567.596% |
| Purple Biotech Ltd. | -14.13 Million USD | 2506.26% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 1532.047% |
| scPharmaceuticals Inc. | -6.54 Million USD | 5297.815% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 2138.064% |
| HilleVax, Inc. | -165.48 Million USD | 305.576% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 13504.137% |
| Tharimmune, Inc. | -10.93 Million USD | 3210.984% |
| Genprex, Inc. | -6.73 Million USD | 5149.209% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 192.243% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 484.577% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 24382.441% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 10356.332% |
| OKYO Pharma Limited | -826.84 Thousand USD | 41243.838% |
| Savara Inc. | 153 Thousand USD | -222250.98% |
| Curis, Inc. | -23.88 Million USD | 1524.193% |
| Daré Bioscience, Inc. | -5.15 Million USD | 6695.635% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 43939.142% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 5579.977% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -28608.608% |
| BeiGene, Ltd. | -2.25 Billion USD | 115.099% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -2657.199% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 155.935% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 283.31% |
| Erasca, Inc. | -37.21 Million USD | 1014.115% |
| bluebird bio, Inc. | 108.57 Million USD | -213.341% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 26515.005% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 10.179% |
| DBV Technologies S.A. | -126.98 Million USD | 367.901% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 26515.005% |
| Moderna, Inc. | -2.9 Billion USD | 111.703% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 3386.293% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 3230.263% |
| Molecular Templates, Inc. | 707 Thousand USD | -48018.388% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 1184.431% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 1.85% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 514.561% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 470.868% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 1154.155% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 1089.635% |
| MacroGenics, Inc. | -66.98 Million USD | 607.87% |
| RenovoRx, Inc. | -1.17 Million USD | 29102.302% |
| Adicet Bio, Inc. | -138.78 Million USD | 345.122% |
| Prime Medicine, Inc. | -27.94 Million USD | 1317.555% |
| Aditxt, Inc. | 18.12 Million USD | -1777.375% |
| Adagene Inc. | -87.62 Million USD | 488.231% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 8267.156% |
| Quantum-Si incorporated | -118.55 Million USD | 386.948% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -844.86% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 4651.625% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 801.307% |
| SciSparc Ltd. | -2.06 Million USD | 16574.431% |
| Vericel Corporation | 1.27 Million USD | -26540.329% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2936.937% |
| Minerva Neurosciences, Inc. | 41 Million USD | -729.663% |
| Generation Bio Co. | 31.44 Million USD | -981.776% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 293.995% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 1200.142% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -191.782% |
| Invivyd, Inc. | -198.47 Million USD | 271.405% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 476.866% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 14288.542% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 580.572% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 5084.571% |
| 2seventy bio, Inc. | 181.71 Million USD | -87.215% |
| ADMA Biologics, Inc. | 90.06 Million USD | -277.72% |
| Clene Inc. | 3.34 Million USD | -10085.539% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 3845.548% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 1681.502% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5372.256% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 198.859% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 1408.466% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -91.481% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 8414.589% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -6701.22% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 6630.946% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 361.079% |
| Evaxion Biotech A/S | 5.28 Million USD | -6334.784% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 402.215% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 359.152% |
| Trevena, Inc. | 2.25 Million USD | -14966.298% |
| Surrozen, Inc. | -32.66 Million USD | 1141.504% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 760.448% |
| Cingulate Inc. | 3.08 Million USD | -10935.744% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 11683.146% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -4633.505% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 3761.486% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 528.876% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 358.799% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 422.333% |
| Clearmind Medicine Inc. | -3.94 Million USD | 8728.667% |
| Kronos Bio, Inc. | -36.05 Million USD | 1043.576% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -3515.655% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -23231.095% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 727.022% |
| Statera Biopharma, Inc. | 14.41 Million USD | -2259.791% |
| ImmunityBio, Inc. | 618.22 Million USD | 44.972% |
| Korro Bio, Inc. | -132.94 Million USD | 355.897% |
| Kineta, Inc. | -4.54 Million USD | 7591.676% |
| BioVie Inc. | -17.73 Million USD | 2018.51% |
| Codexis, Inc. | -43.27 Million USD | 886.201% |
| Celularity Inc. | 65.19 Million USD | -421.855% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 10835.153% |
| Celcuity Inc. | 6.78 Million USD | -4915.059% |
| Virax Biolabs Group Limited | -3.36 Million USD | 10210.035% |
| Cibus, Inc. | -8.07 Million USD | 4311.401% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 8144.384% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -7344.136% |
| IN8bio, Inc. | -16.38 Million USD | 2175.764% |
| Kodiak Sciences Inc. | -103.87 Million USD | 427.506% |
| Annexon, Inc. | -193.75 Million USD | 275.581% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -944891.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 2044.094% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 9783.945% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 67.732% |
| Eyenovia, Inc. | 1.25 Million USD | -26927.605% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -1164.438% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 10590.194% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 1123.241% |
| Arcellx, Inc. | -296.95 Million USD | 214.561% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 1844.063% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 677.829% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 1741.323% |
| Moolec Science SA | 117.61 Thousand USD | -289143.81% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 985.953% |
| Geron Corporation | 14.76 Million USD | -2204.702% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 997.191% |
| Royalty Pharma plc | 5.65 Billion USD | 93.988% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 340.556% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 4967.311% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 6443.575% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 341.736% |
| Humacyte, Inc. | -22.48 Million USD | 1612.928% |
| Structure Therapeutics Inc. | -124.33 Million USD | 373.604% |
| 89bio, Inc. | -289.05 Million USD | 217.694% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 1447.742% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 19180.034% |
| Genelux Corporation | -6.89 Million USD | 5031.106% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 1195.325% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -306.939% |
| Notable Labs, Ltd. | -9.77 Million USD | 3579.92% |
| Liquidia Corporation | -80.17 Million USD | 524.313% |
| Mustang Bio, Inc. | -3.73 Million USD | 9205.915% |
| Immunovant, Inc. | -635.22 Million USD | 153.555% |
| Quantum-Si incorporated | -118.55 Million USD | 386.948% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 2036.899% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 8311.369% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -4138.159% |
| Acasti Pharma Inc. | -23 Million USD | 1578.796% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 10203.174% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2193.601% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 346.985% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 11016.479% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 1630.213% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 1932.07% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 300.969% |
| PepGen Inc. | -60.67 Million USD | 660.733% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 1580.662% |
| United Therapeutics Corporation | -507.7 Million USD | 167.007% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 1878.715% |
| Solid Biosciences Inc. | -47.75 Million USD | 812.454% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 39561.935% |
| Immuneering Corporation | -54.94 Million USD | 719.183% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 8193.207% |
| Silo Pharma, Inc. | -3.52 Million USD | 9752.874% |
| Belite Bio, Inc | -87.27 Million USD | 489.817% |
| XOMA Corporation | -29 Million USD | 1273.093% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 581.204% |
| Bionomics Limited | 227 Million USD | -49.86% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 392.562% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 13530.596% |
| uniQure N.V. | -102.95 Million USD | 430.446% |
| Cassava Sciences, Inc. | -121.13 Million USD | 380.839% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 8267.156% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -730.742% |
| Forte Biosciences, Inc. | -11.96 Million USD | 2944.219% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 11094.667% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -320840.566% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 10590.194% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -3720.292% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 4687.338% |
| Altimmune, Inc. | -134.48 Million USD | 352.959% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -71.76% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 13530.596% |
| Compugen Ltd. | -12.9 Million USD | 2736.369% |
| Peak Bio, Inc. | 10.34 Million USD | -3190.056% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 120310.954% |
| Benitec Biopharma Inc. | -50.58 Million USD | 772.565% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 426.053% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -1631.723% |
| Zura Bio Limited | -99.8 Million USD | 440.858% |
| PolyPid Ltd. | 6.17 Million USD | -5413.728% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -358.981% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -1631.723% |
| Instil Bio, Inc. | 75.35 Million USD | -351.441% |
| argenx SE | -2.02 Billion USD | 116.768% |
| Immunome, Inc. | -97.02 Million USD | 450.614% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 1612.323% |
| Verona Pharma plc | -220.44 Million USD | 254.324% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 574.188% |
| Shattuck Labs, Inc. | -121.42 Million USD | 380.173% |
| CervoMed Inc. | -7.79 Million USD | 4465.504% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 283.396% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 7879.488% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 358.234% |
| Moolec Science SA | 117.61 Thousand USD | -289143.81% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 14968.899% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -2039.822% |
| AnaptysBio, Inc. | -18.15 Million USD | 1974.26% |
| Design Therapeutics, Inc. | -18.15 Million USD | 1974.364% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 583.365% |
| NeurAxis, Inc. | 145.7 Thousand USD | -233391.421% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -2928.819% |
| Lumos Pharma, Inc. | -28.49 Million USD | 1293.967% |
| Achilles Therapeutics plc | -126.92 Million USD | 368.032% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 574.188% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 51980.652% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 1737.623% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -23231.095% |
| Nutriband Inc. | -251.65 Thousand USD | 135282.808% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 2682.925% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 4672.54% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -1333.314% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 176.027% |
| Palisade Bio, Inc. | -12.06 Million USD | 2920.169% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 342.459% |
| Beam Therapeutics Inc. | -262.72 Million USD | 229.489% |
| Neurogene Inc. | -131.95 Million USD | 357.813% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -1459.392% |
| AEON Biopharma, Inc. | -4.88 Million USD | 7071.25% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 190.192% |
| Sesen Bio, Inc. | -112.55 Million USD | 402.255% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 440.674% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 14590.076% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 971.719% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 508.488% |
| Athira Pharma, Inc. | -88.99 Million USD | 482.248% |
| Vaccinex, Inc. | -1.28 Million USD | 26512.811% |
| HCW Biologics Inc. | 2.85 Million USD | -11808.841% |
| XOMA Corporation | -29 Million USD | 1273.093% |
| Nektar Therapeutics | 210.24 Million USD | -61.814% |
| Arvinas, Inc. | -313.8 Million USD | 208.412% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -20862.419% |
| Merus N.V. | -192.88 Million USD | 276.374% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -467.137% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 5003.387% |
| Rezolute, Inc. | -68.16 Million USD | 599.057% |
| Clene Inc. | 3.34 Million USD | -10085.539% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 2679.791% |
| BeyondSpring Inc. | -13.75 Million USD | 2573.261% |
| Synlogic, Inc. | -6.68 Million USD | 5188.96% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -29899.735% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 4123.619% |
| Peak Bio, Inc. | 10.34 Million USD | -3190.056% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 512.76% |
| Krystal Biotech, Inc. | -350.23 Million USD | 197.134% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -174.076% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 301.305% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 10875.467% |
| MannKind Corporation | 143.89 Million USD | -136.414% |
| Ikena Oncology, Inc. | -109.15 Million USD | 411.661% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 4593.422% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 1127.785% |
| Gossamer Bio, Inc. | 180.35 Million USD | -88.626% |
| CohBar, Inc. | -5.93 Million USD | 5836.173% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 1243.596% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -7350.657% |
| Legend Biotech Corporation | -949.39 Million USD | 135.833% |
| Mural Oncology plc | -255.84 Million USD | 232.971% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -956.02% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 7321.882% |
| Disc Medicine, Inc. | -358.28 Million USD | 194.953% |
| Champions Oncology, Inc. | 4.81 Million USD | -6969.763% |
| REGENXBIO Inc. | 54.76 Million USD | -521.16% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 126611.024% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 325.26% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 3874.931% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 521.646% |
| Vaxart, Inc. | -8.24 Million USD | 4228.103% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 777.954% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 367.523% |
| Cellectis S.A. | -43.85 Million USD | 875.731% |
| Longeveron Inc. | -2.9 Million USD | 11798.659% |
| Repare Therapeutics Inc. | -107.85 Million USD | 415.412% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 64.869% |
| Inozyme Pharma, Inc. | 12 Million USD | -2734.03% |
| Revolution Medicines, Inc. | -608.2 Million USD | 155.935% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 27758.293% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 228.32% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 326.689% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 2274.2% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 46072.568% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 103.557% |
| Denali Therapeutics Inc. | -74.86 Million USD | 554.414% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2936.937% |
| Veru Inc. | 4.77 Million USD | -7017.138% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 3125.049% |
| Cingulate Inc. | 3.08 Million USD | -10935.744% |
| Passage Bio, Inc. | 4.58 Million USD | -7319.782% |
| Context Therapeutics Inc. | -14.44 Million USD | 2454.333% |
| Exicure, Inc. | 5.84 Million USD | -5716.328% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 247.67% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 959.735% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -2068.103% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 678.36% |
| Nuvalent, Inc. | -335.38 Million USD | 201.434% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -19515.347% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 556.751% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 3926.738% |
| OmniAb, Inc. | 9.2 Million USD | -3596.588% |
| Anew Medical, Inc. | 1.43 Million USD | -23649.062% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -1976.682% |
| Lipocine Inc. | -4.75 Million USD | 7255.125% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 409.754% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -2133.583% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 771.543% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -1266.692% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 5161.702% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 616.805% |
| Ocugen, Inc. | -32.52 Million USD | 1146.084% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 497.543% |
| Q32 Bio Inc. | -37.94 Million USD | 996.482% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 54271.497% |
| Alumis Inc. Common Stock | -13.52 Million USD | 2614.576% |
| Equillium, Inc. | -22.39 Million USD | 1619.279% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 1430.558% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 1142.693% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 137323.242% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -153.799% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -10537.805% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -103479.334% |
| Dominari Holdings Inc. | 195 Thousand USD | -174360.0% |
| Edesa Biotech, Inc. | -5.26 Million USD | 6559.138% |
| vTv Therapeutics Inc. | -8.91 Million USD | 3915.151% |
| Bio-Techne Corporation | 267.74 Million USD | -27.059% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 2198.815% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 388.073% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 4148.518% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 2789.092% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 238.789% |
| Nkarta, Inc. | 57.29 Million USD | -493.722% |
| BioCardia, Inc. | 212 Thousand USD | -160370.283% |
| Iterum Therapeutics plc | 13.43 Million USD | -2431.604% |